A share price of Fractyl Health Inc [GUTS] is currently trading at $2.26, down -0.88%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The GUTS shares have gain 4.63% over the last week, with a monthly amount glided 61.43%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Fractyl Health Inc [NASDAQ: GUTS] stock has seen the most recent analyst activity on September 15, 2025, when H.C. Wainwright initiated its Buy rating and assigned the stock a price target of $9. Previously, Ladenburg Thalmann started tracking the stock with Buy rating on August 28, 2025, and set its price target to $3.60. On February 28, 2024, Evercore ISI initiated with a Outperform rating. Morgan Stanley started tracking the stock assigning a Overweight rating and suggested a price target of $18 on February 27, 2024. BofA Securities initiated its recommendation with a Buy and recommended $26 as its price target on February 27, 2024.
Fractyl Health Inc experienced fluctuations in its stock price throughout the past year between $0.82 and $3.03. Currently, Wall Street analysts expect the stock to reach $8 within the next 12 months. Fractyl Health Inc [NASDAQ: GUTS] shares were valued at $2.26 at the most recent close of the market. An investor can expect a potential return of 253.98% based on the average GUTS price forecast.
Analyzing the GUTS fundamentals
Trailing Twelve Months sales for Fractyl Health Inc [NASDAQ:GUTS] were 0.00M which represents -100.00% decline. Gross Profit Margin for this corporation currently stands at -185.67% with Operating Profit Margin at -32914.0%, Pretax Profit Margin comes in at -40732.33%, and Net Profit Margin reading is -40732.33%. To continue investigating profitability, this company’s Return on Assets is posted at -1.07, Equity is -36.45 and Total Capital is -1.03. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of-19.57.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 2.23 points at the first support level, and at 2.19 for the second support level. However, for the 1st resistance point, the stock is sitting at 2.31, and for the 2nd resistance point, it is at 2.35.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Fractyl Health Inc [NASDAQ:GUTS] is 4.27. In addition, the Quick Ratio stands at 4.27 and the Cash Ratio stands at 4.16.
Transactions by insiders
Recent insider trading involved Rajagopalan Harith, Chief Executive Officer, that happened on Dec 04 ’25 when 10416.0 shares were purchased. Director, Royan Ajay completed a deal on Mar 14 ’25 to buy 17901.0 shares. Meanwhile, Director Barnes Kelly Ann bought 31000.0 shares on Mar 14 ’25.
